Skip to main content
. 2021 Feb 1;12(2):139. doi: 10.1038/s41419-021-03431-2

Fig. 5. FL-GSDME aggravated cisplatin-induced cell injury and pyroptosis in human TECs.

Fig. 5

Human TECs (HK-2) were transfected with FL-GSDME or the corresponding control and subsequently treated with cisplatin (10 μg/mL) for 24 h. a Protein expression of HA-FL-GSDME with HA and GSDME antibody. b Transcriptional levels of NGAL and KIM-1 (n = 3). c Representative bright-field microscopic images of cells. Red arrowheads indicate large bubbles from the plasma membrane (scale bar = 50 μm). d LDH release in cells overexpressing FL-GSDME (n = 6). e Effect of FL-GSDME on the cell viability (n = 6). f, g IL-1β and IL-6 released in culture medium of cells. h Effect of FL-GSDME on p-p65 protein levels (n = 3). *P < 0.05, **P < 0.01, and ***P < 0.001.